Newton Biocapital II Partners
0767.828.541 · rovalta.com · 27/09/2026
Newton Biocapital II Partners
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBONewton Biocapital II Partners is a Private limited company incorporated in 2021. Its main activity is: Other financial service activities, except insurance and pension funding n.e.c.. Its registered office is in Woluwe-Saint-Pierre.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0767.828.541
- Incorporation
- 04/05/2021
- Legal form
- Private limited company
- Registered office
- Avenue de Tervueren 273
1150 Woluwe-Saint-Pierre · BruxellesSee on map - Contributed capital
- 8 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 8,3 k € | -88.7% | 73,2 k € | -21.8% | 93,6 k € | +154% | -174,4 k € | -13943% | -1,2 k € |
| EBITDA | 7,2 k € | -90.0% | 72 k € | -22.1% | 92,4 k € | +153% | -174,7 k € | -9946% | -1,7 k € |
| Operating result | 7,1 k € | -90.1% | 72 k € | -22.1% | 92,4 k € | +153% | -174,7 k € | -9946% | -1,7 k € |
| Net result | 4,1 k € | -93.6% | 63,8 k € | -30.2% | 91,4 k € | +152% | -175,5 k € | -9786% | -1,8 k € |
| Balance sheet | |||||||||
| Equity | -10,1 k € | +28.8% | -14,2 k € | +81.8% | -77,9 k € | +54.0% | -169,3 k € | -2820% | 6,2 k € |
| Total assets | 49,2 k € | -30.6% | 70,9 k € | +4.0% | 68,2 k € | +1968% | 3,3 k € | -81.2% | 17,5 k € |
| Cash | 44,9 k € | -35.0% | 69,1 k € | +87.1% | 36,9 k € | +1024% | 3,3 k € | -69.8% | 10,9 k € |
| Debts | 59,3 k € | -30.3% | 85,1 k € | -41.8% | 146,1 k € | -15.3% | 172,6 k € | +1431% | 11,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20255 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
Avenue de Tervueren 273 1150 Woluwe-Saint-Pierre| Company | CBE no. |
|---|---|
| 0850.679.013 | |
Affix Corporate Finance● Active | 0861.703.557 |
A Q INVEST● Active | 0892.924.986 |
AQ PARTNERS● Active | 0502.699.431 |
| 0414.101.611 | |
| 0726.424.387 | |
CYRILLE BARETTE-AVOCAT● Active | 0886.316.021 |
| 0414.448.930 | |
| 0414.927.002 | |
HDI Global Belgium VAT Unit● Active | 0746.998.681 |
JERSERAV● Active | 1036.688.092 |
LATOUR● Active | 0507.666.128 |
LATOUR & PETIT● Active | 0475.331.474 |
LES AMIS D'ISAAC● Active | 0743.763.831 |
L&P MANAGEMENT● Active | 1035.538.940 |
Madyol● Active | 0691.614.552 |
Newton Biocapital II● Active | 0779.335.513 |
| 0685.758.425 | |
| 0674.831.275 | |
Newton Biocapital Partners● Active | 0673.852.565 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 04/05/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 8 months |
| Filing date | 02/06/2026 | 29/07/2025 | 23/07/2024 | 06/06/2023 | 23/08/2022 |
| General meeting | 02/06/2026 | 03/06/2025 | 04/06/2024 | 06/06/2023 | 07/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/06/2026 | 02/06/2026 | French | |
| Abridged model | 31/12/2024 | 03/06/2025 | 29/07/2025 | French | |
| Abridged model | 31/12/2023 | 04/06/2024 | 23/07/2024 | French | |
| Abridged model | 31/12/2022 | 06/06/2023 | 06/06/2023 | French | |
| Abridged model | 31/12/2021 | 07/06/2022 | 23/08/2022 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20254,1 k €↓
- 2024Annual accounts 202463,8 k €↓
- 2023Annual accounts 202391,4 k €↑
- 2022Annual accounts 2022-175,5 k €↓
- 2021Annual accounts 2021-1,8 k €
- 04/05/2021IncorporationPrivate limited company